Compare Bank of Nova Scotia (BNS) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Nova Scotia vs Smith & Nephew plc — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Bank of Nova Scotia is far larger — about 8.6× Smith & Nephew plc's market cap, and Bank of Nova Scotia pays the higher dividend (3.64%). Which is the better fit depends on your goals.
| BNS | SNN | |
|---|---|---|
Market Cap | $108.32B | $12.54B |
Sector | Financials | Health |
52-Week High | $90.29 | $38.70 |
52-Week Low | $56.41 | $28.73 |
Dividend Yield | 3.64% | 2.65% |
Enterprise Value | — | $15.57B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
